News coverage about Alphatec Holdings (NASDAQ:ATEC) has trended somewhat negative this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Alphatec Holdings earned a coverage optimism score of -0.02 on Accern’s scale. Accern also gave media stories about the medical technology company an impact score of 83 out of 100, meaning that recent news coverage is very likely to have an impact on the company’s share price in the near term.
Alphatec Holdings (NASDAQ:ATEC) traded up 1.81% during mid-day trading on Friday, hitting $1.69. The company had a trading volume of 40,748 shares. The company’s 50 day moving average price is $1.97 and its 200-day moving average price is $2.73. Alphatec Holdings has a 12-month low of $1.60 and a 12-month high of $9.65.
Alphatec Holdings Company Profile
Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.
Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.